Home › Companies › 3D Systems

One of the two oldest names in the field; it invented stereolithography. Sells SLA, SLS and metal machines plus healthcare and dental printing, materials and software. Has spent recent years shedding non-core units to cut losses.

Live chart and quote by TradingView. Data may be delayed.

1. 2021
   2021

   Full-year revenue of 615.6 million dollars

   Source

2. 2022
   2022

   Revenue falls 12.6 percent to 538.0 million dollars, net loss 122.7 million

   Source

3. 2023
   May 2023

   Bids for Stratasys

   Proposed on 30 May 2023 to pay 7.50 dollars in cash plus 1.2507 new 3D Systems shares for each Stratasys share.

   Source

4. Sep 2023

   Stratasys turns down the raised offer and ends talks

   3D Systems valued its revised cash-and-stock offer at more than 27 dollars a share. On 12 September 2023 the Stratasys board said it was not a superior proposal and terminated discussions.

   Source

5. 2023

   Revenue 488.1 million dollars, net loss 370.4 million

   The loss included a 297.7 million dollar goodwill impairment in the fourth quarter, and the company delayed its annual report to finish closing procedures.

   Source

6. 2024
   2024

   Revenue 440.1 million dollars, net loss 255.6 million

   Repurchased 87.2 million dollars of convertible notes due November 2026 during the year.

   Source

7. 2025
   Apr 2025

   Sells Geomagic for 119.4 million dollars in cash

   The software sale closed on 1 April 2025.

   Source

8. Oct 2025

   Sells Oqton and 3DXpert for 3.3 million dollars plus a royalty

   Completed the sale to Hubb Global Holdings on 31 October 2025. The revenue-based royalty was valued at 7.1 million dollars.

   Source

9. 2025

   Revenue 386.9 million dollars, net income 29.9 million

   Revenue fell 12 percent on lower volumes and divestitures, and the profit included the gains on the software sales. Year-end cash was 95.6 million dollars against 90.3 million of debt.

   Source

10. 2026
    Aug 2026

    Second-quarter revenue 94.6 million dollars, net loss 12.9 million

    Revenue was flat year on year and up 1.4 percent excluding divestitures; healthcare grew 6.8 percent.

    Source

Informational only, not investment advice. Timeline entries are compiled by hand from public sources and can lag real events. Figures come from company reports and news, not from us. Private companies rarely publish financials; where a figure is not disclosed we say so instead of estimating it.